Department of Orthopaedics, Darlington Memorial Hospital, Darlington, County Durham, DL3 6HX, UK.
Skeletal Radiol. 2013 Jan;42(1):107-11. doi: 10.1007/s00256-012-1527-x. Epub 2012 Oct 17.
To identify the benefits of ultrasound-guided radiofrequency ablation of Morton's neuroma as an alternative to surgical excision.
We studied a consecutive cohort of surgical candidates for Morton's neurectomy who we referred, instead, for radiofrequency ablation (RFA). Under local anaesthetic, RFA was performed under ultrasound guidance, by a single radiologist. This out-patient procedure was repeated after 4 weeks if necessary. We followed patients for a minimum of 6 months to assess their change in visual analogue pain scores (VAS), symptom improvement, complications and progression to surgical excision.
Thirty feet in 25 patients were studied. There were 4 men and 21 women with an average age of 55 years (range 33-73 years). All had tried previous methods of conservative management. Forty percent presented with 2nd space neuromas and 60% with 3rd space ones. The average number of treatment sessions was 1.6 (range 1-3, mode 1). Prior to treatment, all patients had pain on activity (VAS average: 6.0, range 3-9). Post-treatment there was a statistically significant reduction in pain scores (post-RFA VAS average: 1.7, range 0-8, p < 0.001). The average overall symptom improvement was 76%. There was one minor complication of temporary nerve irritation. Three neuromas (10%) have progressed to surgical excision; 1 patient has ongoing, unchanged pain with no obvious cause. At 6 months, 26 out of 30 feet had a satisfactory outcome.
Ultrasound-guided RFA has successfully alleviated patients' symptoms of Morton's neuroma in >85% of cases. Only 10% have proceeded to surgical excision in the short term.
确定超声引导下射频消融治疗 Morton 神经瘤的优势,作为手术切除的替代方法。
我们研究了一组连续的接受 Morton 神经瘤切除术的手术候选患者,我们建议他们选择射频消融 (RFA)。在局部麻醉下,由一位放射科医生在超声引导下进行 RFA。如果需要,在 4 周后再次进行该门诊程序。我们对患者进行至少 6 个月的随访,以评估他们的视觉模拟疼痛评分 (VAS)变化、症状改善、并发症以及是否需要手术切除。
25 例患者的 30 只脚参与了研究。4 例为男性,21 例为女性,平均年龄为 55 岁(范围 33-73 岁)。所有患者均尝试过先前的保守治疗方法。40%的患者出现第 2 间隙神经瘤,60%的患者出现第 3 间隙神经瘤。平均治疗次数为 1.6 次(范围 1-3,模式 1)。治疗前,所有患者活动时均有疼痛(VAS 平均:6.0,范围 3-9)。治疗后疼痛评分有显著降低(RFA 后 VAS 平均:1.7,范围 0-8,p<0.001)。总体症状改善平均为 76%。有 1 例轻微的神经刺激暂时并发症。3 例神经瘤(10%)进展为手术切除;1 例患者持续存在无明显原因的疼痛,无变化。6 个月时,30 只脚中的 26 只脚获得了满意的结果。
超声引导下 RFA 成功缓解了超过 85%的 Morton 神经瘤患者的症状。只有 10%的患者在短期内需要进行手术切除。